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Introduction
Currently, dendritic cells (DC) are tested as vectors for
cancer immunotherapy. However, little is known about
the mechanisms regulating DC migration. Sphingosine-
kinase (SphK) and its catalytic product Sphingosine-1-
phosphate (S1P) play a central role in processes such as
cellular differentiation, survival and migration, which are
often disregulated in cancer. Here, we examined the role
of SphK and S1P in migration of DC.
Methods
DC were generated in the presence of GM-CSF and IL-4 for
5 days, then matured with PGE2, TNF-α and IL1-β for 2
days. Expression of SphK and S1P-receptors was examined
by RT-PCR. In transwell assays migration of immature (i)
and mature (m) DC towards SDF-1, MiP-1a, MCP,
6Ckine, MiP-3β [100 ng/ml] and S1P [10-5 M] was tested
for being dependent on SphK using the SphK inhibitor
Dihydrosphingosine [DHS, 10-6 M]. The role of S1P3
receptor in S1P-induced migration was tested using the
S1P3-inhibitor Suramin [10-6 M]. In parallel, Ca2+-flux was
assessed by FACS with Fura Red.
Results
SphK expression was declining from iDC to mDC to anti-
gen-loaded mDC. Expression levels of S1P receptors were
S1P1>S1P2 = S1P3, unrelated to maturation stage or anti-
gen uptake. IDC migrated on SDF-1, MIP-1α, MCP and
S1P, whereby S1P combined with a chemokine acted syn-
ergistic. MDC migrated on 6Ckine and MIP-3β, but not on
S1P. Pre-treatment with DHS inhibited migration of iDC
but not mDC, showing that SphK is required for iDC
migration. Pre-treatment with Suramin inhibited iDC
migration in response to S1P, demonstrating a mediation
via S1P3. Chemokine induced Ca2+-flux was inhibited by
DHS, indicating that SphK-mediated migration might be
Ca2+-dependent.
Conclusion
Our results suggest a role for SphK/S1P in accumulation
of peripheral iDC at sites of antigen invasion. These find-
ings could provide a new approach to optimise DC-based
cancer immunotherapy by therapeutic modulation of
SphK/S1P and have to be verified in an animal model in
the next step.
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